Alopecia

A combined treatment modality comprising ILC and carboxy therapy is an effective treatment option for stimulating early hair growth in individuals with AA and patchy hair loss. Alopecia areata (AA) is an autoimmune disease that has no standard medical treatment. This prevalent autoimmune condition follows an unpredictable course and is associated with patchy hair loss....

Patients with alopecia areata (AA) may have an increased risk of endothelial dysfunction and subsequent cardiovascular complications. A case-control study found that patients with AA had lower reactive hyperemia index (RHI) scores than patients without AA, indicating the potential need for routine cardiovascular screening in patients with AA. As a chronic autoimmune disease, alopecia areata...

Shared decision-making (SDM) is a crucial aspect of ensuring patients with alopecia areata (AA) are satisfied with the quality of their treatment. Clinicians are encouraged to implement SDM as often as possible when devising a treatment strategy for patients with AA. The treatment landscape for alopecia areata (AA) can be complex to navigate. With several...

Racial disparities can act as a barrier to appropriate access to care in pediatric patients with vitiligo and alopecia areata. Virtual group visits may help fill the gap in access to care among pediatric patients of color. Vitiligo and alopecia areata (AA) disproportionately affect the mental and emotional health of pediatric patients of color. Racial...

Patients with alopecia areata (AA) may be at a higher risk of mental health problems, such as anxiety and depression. As mental health conditions may have a negative effect on patient satisfaction scores, it is important for clinicians to tailor their communication strategies to address mental health and improve satisfaction in patients with AA. Patient...

Pediatric patients with alopecia areata (AA) may experience a severe burden of disease that can have negative emotional and financial effects. Pediatric AA affects not only the patients themselves but also their families, which warrants appropriate medical support from physicians. Alopecia areata (AA) is an autoimmune disorder characterized by chronic hair loss. Although it’s not...

In this MD Newsline exclusive interview with dermatologist Dr. Victoria Barbosa, we discuss how to provide culturally sensitive care and overcome language barriers. MD Newsline: How have you been able to implement culturally sensitive care in your practice?  Dr. Victoria Barbosa: “For me, the first step in providing culturally sensitive care to patients is approaching...

In this MD Newsline exclusive interview with dermatologist Dr. Victoria Barbosa, we discuss disparities in diagnosing and treating central centrifugal cicatricial alopecia (CCCA) before and during the COVID-19 pandemic. MD Newsline: What disparities in diagnosing and treating CCCA have you observed in your clinical practice? Dr. Victoria Barbosa: “Recent research has shown us that CCCA...

In this MD Newsline exclusive interview with dermatologist Dr. Victoria Barbosa, we discuss the latest research on central centrifugal cicatricial alopecia (CCCA) diagnosis, prognosis, and treatment. We also discuss how to improve diversity and inclusion in dermatology clinical trials. MD Newsline: Is there any research that excites you or that you think is important for physicians...